MedinCell S.A.
General ticker "MDCLF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.1B (TTM average)
MedinCell S.A. follows the US Stock Market performance with the rate: 23.3%.
Estimated limits based on current volatility of 0.0%: low 30.26$, high 30.26$
Short-term MDCLF quotes
Long-term MDCLF plot
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | €9.94MM | €9.16MM | €25.54MM |
| Operating Expenses | €33.97MM | €30.14MM | €36.38MM |
| Operating Income | €-24.02MM | €-20.98MM | €-10.84MM |
| Non-Operating Income | €-7.99MM | €-3.97MM | €-7.44MM |
| Interest Expense | €3.93MM | €4.62MM | €5.09MM |
| R&D Expense | €27.93MM | €21.08MM | €24.31MM |
| Income(Loss) | €-32.01MM | €-24.95MM | €-18.28MM |
| Taxes | €-4.08MM | €0.09MM | €0.16MM |
| Net Income(Loss)* | €-32.01MM | €-25.04MM | €-18.44MM |
| Stockholders Equity | €-42.29MM | €-40.82MM | €-16.37MM |
| Inventory | €0.76MM | €0.02MM | €0.00MM |
| Assets | €29.34MM | €36.95MM | €90.45MM |
| Operating Cash Flow | €-21.00MM | €-11.92MM | €19.46MM |
| Capital expenditure | €1.03MM | €1.19MM | €1.66MM |
| Investing Cash Flow | €1.30MM | €-0.61MM | €-13.21MM |
| Financing Cash Flow | €1.56MM | €25.53MM | €33.32MM |
| Earnings Per Share** | €-1.27 | €-0.88 | €-0.63 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.